Loading...
Please wait, while we are loading the content...
Similar Documents
An Evaluation Of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors In Patients With Diabetes Mellitus*
| Content Provider | Semantic Scholar |
|---|---|
| Author | Stryker, Matthew D. Kane, Michael P. Busch, Robert S. |
| Copyright Year | 2016 |
| Abstract | This is a prospective, observational, Institutional Review Board-approved study from an endocrinology practice involving patients with DM referred to a pharmacist-managed PCSK9i clinic. Upon referral, the following data were collected: patient demographic information, indication for referral, history of prior antilipemic therapy, notably statin use, and adverse medication events related to previous therapies. |
| Starting Page | 720 |
| Ending Page | 720 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| DOI | 10.1016/j.jacl.2016.03.098 |
| Volume Number | 10 |
| Alternate Webpage(s) | https://www.lipid.org/util/eposters/PDF/187.pdf |
| Alternate Webpage(s) | https://doi.org/10.1016/j.jacl.2016.03.098 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |